#healthcare #CureBell #WillBase

WillBase Hits Milestone with CureBell

WillBase Inc., headquartered in Chuo City, Tokyo, is delighted to announce that its over-the-counter drug and supplement selection support website, CureBell, has surpassed a remarkable milestone of 2 million unique users. This achievement reflects the growing demand for accessible healthcare solutions, driven by the company's vision of making healthcare ordinary and commonplace.

What Is CureBell?

CureBell is a free web service designed to assist users in selecting the best OTC medications and supplements tailored to their symptoms and needs. Users simply choose their symptoms or goals, and the platform provides optimal options from a vast database of products. This service is particularly beneficial for those who cannot dedicate time to research or struggle to make choices in stores, acting as a powerful tool for self-care.

Background of 2 Million Users

Recently, the proliferation of self-medication has led to an increasing number of individuals facing the challenge of identifying suitable medications from a bewildering array of options. CureBell addresses this problem by offering a recommendation feature that presents choices based on objective data, proving invaluable as a pre-purchase information tool in drugstores.

The platform's growth was further accelerated by two significant updates planned for 2025 and 2026, including the introduction of a product comparison feature and a chatbot powered by AI for medication inquiries. These enhancements enable users to compare, consider, and purchase their selected products in a seamless one-stop service, ultimately contributing to reaching the milestone of 2 million users.

Recent Major Updates

1. AI Medication Consultation Chatbot
A new interactive AI feature has been launched, allowing users to detail their conditions—such as symptoms, age, and medications—and receive tailored recommendations for OTC drugs. Unlike other AI applications that may reference questionable information online, this service relies on CureBell's structured database featuring reliable sources like product labeling information. This minimizes the risks associated with misinformation, yielding precise and evidence-based advice. Recent user surveys show that about 75% of participants felt their issues were resolved effectively, appreciating the ability to consult using straightforward, intuitive language.

2. Added Product Comparison Feature
Users can now freely select and compare multiple products, generated in clear comparison tables. This new feature displays product photos, lowest prices from major e-commerce sites, effectiveness, overall user satisfaction ratings, and a unique 'symptom response level' according to an algorithm—all side by side. This approach aids consumers in making informed decisions based not just on price but also on factual data and visual cues, fostering confidence in their medication choices. Users can tap on any card in the comparison tables to swiftly access detailed pages for ingredient verification and purchase consideration.

3. Expanded Purchase Support Functionality
Enhancements enable users to find nearby drugstores selling selected items directly from product pages, also providing links to the lowest prices on major e-commerce websites. This enables the service to cater to immediate needs and helps users discover where to buy their desired products at competitive prices.

Future Aspirations

Looking ahead, WillBase plans to enhance the AI consultation feature further while establishing partnerships with external services and manufacturers. Aiming to evolve CureBell into an individualized